Pharmacological Mechanisms of Ursolic Acid Derivative Against Prostate Cancer via Regulating Cytoskeletal Homeostasis and Apoptotic Pathways
Huiyue Shen, Zhaolan Ni, Haibo Guo, Xiaofeng Liu, Yaru Zhao, Xuan He, Yinghan Liu, Yan Zhao, Hongbo Teng · 2026
Read Pharmacological Mechanisms of Ursolic Acid Derivative Against Prostate Cancer via Regulating Cytoskeletal Homeostasis and Apoptotic Pathways by Huiyue Shen, Zhaolan Ni, Haibo Guo, Xiaofeng Liu, Yaru Zhao, Xuan He, Yinghan Liu, Yan Zhao, Hongbo Teng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13209419.txt.
Description
Huiyue Shen and co-authors make new forms of a plant compound and test the best one against prostate cancer, in work dated 2026. The parent compound kills tumor cells in the lab, but it dissolves poorly in water and targets weakly. Those flaws have slowed its move to the clinic.
The team made forty new versions, each with one of seven fat loving charged groups added at a set position. Tests on cancer cells picked out one strong version. Gene and protein work traced how it acts, through cell skeleton balance and cell death paths. In mice with tumors, the lead version slowed growth and proved acceptably safe.
Catalog record
| CREATOR | Huiyue Shen, Zhaolan Ni, Haibo Guo, Xiaofeng Liu, Yaru Zhao, Xuan He, Yinghan Liu, Yan Zhao, Hongbo Teng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |